Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-22

Clinical Trial Update: Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Tian Ma Bian Chun Zhi Gan tablets for vascular dementia with cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tian Ma Bian Chun Zhi Gan tablets

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Vascular Dementia, Cognitive Impairment | Phase 2 | Status: UNKNOWN